GlaxoSmithKline

  • Glaxo agrees to pay $956.8 million criminal fine

    It’s probably not the way GlaxoSmithKline (GSK) had hoped to start the second half of the year. The U.S. unit of GSK today agreed to plead guilty and pay a criminal fine of $956.8 million for marketing drugs for unapproved uses.

  • Glaxo has right to sell generic Paxil

    Good news for GlaxoSmithKline Plc. (GSK) U.S. District Judge Joel Pisano ruled yesterday that the pharmaceutical giant has the right to sell an authorized copy of its anti-depressant, Paxil CR, to Canadian pharmaceutical company Apotex Inc.

  • Glaxo agrees to pay $3 billion to settle marketing probes

    Today GlaxoSmithKline (GSK), the U.K.’s biggest drug company, announced that it has agreed to pay the U.S. government $3 billion to settle several criminal and civil probes related to its sales and marketing practices.

  • Inside Experts: Lessons learned from Lauren Stevens

    The Laura Stevens case proves it’s in-house counsels’ job to know what goes on at their company.

  • Denture debacle dismissed

    U.S. District Judge Cecilia Altonaga wasted no time in sinking her teeth into the meat of the first of many lawsuits leveled against Procter & Gamble’s (P&G) Fixodent denture cream. The first of dozens of such cases filed over alleged zinc poisoning was dismissed by Judge Altonaga in pretrial proceedings...

Advertisement. Closing in 15 seconds.